Published in Physician Law Weekly, January 4th, 2006
"The goal of the present study was to characterize outcome and predictors of outcome of treatment interruption (TI) in highly active antiretroviral therapy (HAART)-treated patients."
"A systematic chart/database review was conducted to identify patients with nadir CD4 cell counts >200 cells/mm3 and without acquired immunodeficiency syndrome -defining illnesses who underwent a TI," scientists in Canada report.
According to A.R. Toulson and colleagues at the University of British Columbia, "Collected data included...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.